GILEAD SCIENCES, INC. (GILD)
GILEAD SCIENCES, INC. (GILD) public financial performance, SEC filing summary, and valuation metrics.
Financial highlights
- Contract Revenue: 2573000000 usd (2026-03-31)
- Operating Income: 2586000000 usd (2026-03-31)
- Net Income: 2021000000 usd (2026-03-31)
- Operating Income: 10022000000 usd (2025-12-31)
- Net Income: 8510000000 usd (2025-12-31)
- Contract Revenue: 11467000000 usd (2025-12-31)
- Net Income: 3052000000 usd (2025-09-30)
- Contract Revenue: 2940000000 usd (2025-09-30)
- Operating Income: 3327000000 usd (2025-09-30)
- Net Income: 1960000000 usd (2025-06-30)
- Operating Income: 2474000000 usd (2025-06-30)
- Contract Revenue: 2799000000 usd (2025-06-30)
- Operating Income: 2237000000 usd (2025-03-31)
- Contract Revenue: 2474000000 usd (2025-03-31)
- Net Income: 1315000000 usd (2025-03-31)
- Operating Income: 1662000000 usd (2024-12-31)
- Contract Revenue: 10855000000 usd (2024-12-31)
- Net Income: 480000000 usd (2024-12-31)
- Operating Income: 888000000 usd (2024-09-30)
- Contract Revenue: 2826000000 usd (2024-09-30)
Valuation snapshot
- market cap: 187506020000
- pe ratio: 20.38005386